NMTR Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 2.40%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $11,011.00

9 Meters Biopharma Insider Trading History Chart

9 Meters Biopharma Share Price & Price History

^$0.01

▼ -0.01 (-45.45%)

As of 09/29/2023 01:00 AM ET

Days: 30 | 90 | 365

Watch SHOCKING Footage of AI Facility with Ties to Elon Musk

From Legacy Research | Ad

I recently traveled more than 3,000 miles and shot this video outside what could end up being Elon Musk’s biggest secret.

Most people don’t know about this facility, but it could be the most important AI project in the world.

What’s happening inside these walls is so important that our government has declared it a matter of national security.

Click here to see the details

9 Meters Biopharma Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/21/2023	Bethany Sensenig	CFO	Sell	9,100	$1.21	$11,011.00	41,077
7/6/2022	John Temperato	CEO	Buy	125,000	$0.23	$28,750.00	1,427,522
7/1/2022	Mark A. Sirgo	Director	Buy	175,000	$0.25	$43,750.00	1,454,045
3/3/2022	John Temperato	CEO	Buy	100,000	$0.56	$56,000.00
3/3/2022	Mark A. Sirgo	Director	Buy	86,450	$0.58	$50,141.00
12/2/2021	Mark A. Sirgo	Director	Buy	50,000	$0.89	$44,500.00
11/18/2021	John Temperato	CEO	Buy	50,000	$1.05	$52,500.00
11/18/2021	Mark A. Sirgo	Director	Buy	20,000	$1.06	$21,200.00
9/14/2021	Edward J. Sitar	CFO	Buy	15,000	$1.22	$18,300.00
9/7/2021	Mark A. Sirgo	Director	Buy	73,529	$1.36	$99,999.44
8/24/2021	Michael T. Constantino	Director	Buy	18,000	$1.14	$20,520.00
8/20/2021	Mark A. Sirgo	Director	Buy	25,000	$1.10	$27,500.00
8/18/2021	John Temperato	CEO	Buy	25,000	$1.05	$26,250.00	1,102,522
6/25/2021	Israel Gp Ltd. Orbimed	Major Shareholder	Sell	15,989,876	$1.21	$19,347,749.96
6/23/2021	Israel Gp Ltd. Orbimed	Major Shareholder	Sell	841,650	$1.36	$1,144,644.00
4/5/2021	Edward J. Sitar	CFO	Buy	50,000	$1.00	$50,000.00	179,338
4/5/2021	John Temperato	CEO	Buy	100,000	$1.00	$100,000.00	1,077,522
4/5/2021	Mark A. Sirgo	Director	Buy	300,000	$1.00	$300,000.00	1,074,066

66,000% upside on tiny biotech?

From Behind the Markets | Ad

The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.

Get all the details here >>>

SEC Filings (Institutional Ownership Changes) for 9 Meters Biopharma (NASDAQ:NMTR)

22.34% of 9 Meters Biopharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

9 Meters Biopharma Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/16/2023	Sabby Management LLC	1,103,645	$1.53M	1.3%	+203,149.5%	7.698%
5/12/2023	CIBC Asset Management Inc	32,722	$45K	0.0%	N/A	0.228%
5/12/2023	HRT Financial LP	18,249	$25K	0.0%	-57.1%	0.127%
2/15/2023	Laurion Capital Management LP	227,910	$0.29M	0.0%	-95.0%	1.760%
2/15/2023	Millennium Management LLC	40,089	$51K	0.0%	-95.8%	0.310%
2/14/2023	Two Sigma Investments LP	47,617	$60K	0.0%	-94.5%	0.368%
2/13/2023	Renaissance Technologies LLC	73,168	$92K	0.0%	-95.6%	0.565%
2/13/2023	Geode Capital Management LLC	108,825	$0.14M	0.0%	-95.3%	0.840%
2/13/2023	GSA Capital Partners LLP	109,685	$0.14M	0.0%	-95.3%	0.847%
2/10/2023	HRT Financial LP	42,530	$53K	0.0%	+202.2%	0.328%
2/9/2023	ODonnell Financial Services LLC	43,410	$55K	0.5%	-95.1%	0.335%
2/7/2023	Commonwealth Equity Services LLC	38,141	$48K	0.0%	-90.3%	0.295%
1/19/2023	Adviser Investments LLC	21,429	$49K	0.0%	-92.3%	0.165%
11/16/2022	Requisite Capital Management LLC	300,000	$65K	0.0%	N/A	2.317%
11/15/2022	Two Sigma Investments LP	860,403	$0.19M	0.0%	+7,611.8%	6.641%
11/15/2022	Vanguard Group Inc.	12,561,009	$2.70M	0.0%	+9.2%	96.959%
11/15/2022	Laurion Capital Management LP	4,558,200	$0.98M	0.0%	+0.1%	35.198%
11/15/2022	Commonwealth Equity Services LLC	394,592	$84K	0.0%	+35.9%	3.047%
11/14/2022	Renaissance Technologies LLC	1,662,200	$0.36M	0.0%	+254.2%	12.831%
11/14/2022	Ergoteles LLC	911,451	$0.20M	0.0%	-8.5%	7.036%
11/7/2022	Virtu Financial LLC	228,595	$49K	0.0%	+25.6%	1.765%
10/31/2022	Valeo Financial Advisors LLC	209,688	$45K	0.0%	+5.8%	1.619%
8/15/2022	State Street Corp	806,171	$0.21M	0.0%	-79.0%	0.311%
8/15/2022	Laurion Capital Management LP	4,553,084	$1.19M	0.0%	N/A	1.757%
8/15/2022	Millennium Management LLC	1,850,825	$0.48M	0.0%	N/A	0.714%
8/13/2022	Virtu Financial LLC	181,983	$47K	0.0%	N/A	0.070%
8/13/2022	Renaissance Technologies LLC	469,300	$0.12M	0.0%	-79.1%	0.181%
8/12/2022	Northern Trust Corp	450,126	$0.12M	0.0%	-78.1%	0.174%
8/11/2022	UBS Group AG	114,914	$30K	0.0%	+301.3%	0.044%
8/8/2022	Curi Wealth Management LLC	2,072,771	$0.54M	0.1%	+17,757.9%	0.800%
8/8/2022	Y Intercept Hong Kong Ltd	184,315	$48K	0.0%	N/A	0.071%
7/19/2022	Commonwealth Equity Services LLC	290,402	$75K	0.0%	+38.0%	0.112%
7/14/2022	Adviser Investments LLC	286,248	$75K	0.0%	+24.0%	0.110%
6/7/2022	Bank of America Corp DE	42,400	$25K	0.0%	-63.9%	0.016%
5/16/2022	California State Teachers Retirement System	97,334	$58K	0.0%	-21.3%	0.038%
5/16/2022	Goldman Sachs Group Inc.	80,134	$48K	0.0%	-35.9%	0.031%
5/16/2022	State Street Corp	3,829,916	$2.30M	0.0%	+2.5%	1.483%
5/13/2022	Renaissance Technologies LLC	2,247,100	$1.35M	0.0%	N/A	0.870%
5/13/2022	Northern Trust Corp	2,057,552	$1.23M	0.0%	-3.7%	0.797%
5/13/2022	Vanguard Group Inc.	11,698,118	$7.01M	0.0%	-1.2%	4.530%
5/12/2022	BlackRock Inc.	13,990,407	$8.39M	0.0%	-1.2%	5.418%
5/11/2022	GSA Capital Partners LLP	419,858	$0.25M	0.0%	-15.3%	0.163%
5/4/2022	Adviser Investments LLC	230,888	$0.14M	0.0%	+261.0%	0.089%
5/4/2022	Commonwealth Equity Services LLC	210,402	$0.13M	0.0%	+22.3%	0.081%
2/16/2022	Ghost Tree Capital LLC	3,250,000	$3.18M	1.1%	+18.2%	1.271%
2/14/2022	Blair William & Co. IL	81,912	$80K	0.0%	+192.5%	0.032%
2/14/2022	GSA Capital Partners LLP	495,783	$0.49M	0.1%	+3,414.2%	0.194%
2/9/2022	Principal Financial Group Inc.	68,709	$67K	0.0%	-23.0%	0.027%
2/8/2022	ProShare Advisors LLC	49,462	$48K	0.0%	+72.8%	0.019%
2/8/2022	Northern Trust Corp	2,136,520	$2.09M	0.0%	+2.1%	0.836%
2/7/2022	SG Americas Securities LLC	57,608	$56K	0.0%	-46.6%	0.023%
1/31/2022	Commonwealth Equity Services LLC	172,102	$0.17M	0.0%	+12.4%	0.067%
1/31/2022	Adviser Investments LLC	63,955	$63K	0.0%	N/A	0.025%
1/25/2022	J.W. Cole Advisors Inc.	45,000	$44K	0.0%	+50.0%	0.018%
11/16/2021	Schonfeld Strategic Advisors LLC	39,300	$51K	0.0%	N/A	0.015%
11/16/2021	Captrust Financial Advisors	29,844	$39K	0.0%	-74.8%	0.012%
11/16/2021	Two Sigma Securities LLC	24,834	$32K	0.0%	N/A	0.010%
11/16/2021	Metropolitan Life Insurance Co NY	64,133	$83K	0.0%	N/A	0.025%
11/12/2021	Geode Capital Management LLC	3,624,058	$4.71M	0.0%	+7.4%	1.423%
11/10/2021	Mercer Global Advisors Inc. ADV	60,000	$78K	0.0%	N/A	0.024%
11/10/2021	Panagora Asset Management Inc.	315,867	$0.41M	0.0%	N/A	0.124%
11/10/2021	Prentice Wealth Management LLC	29,000	$38K	0.0%	+59.3%	0.011%
11/10/2021	Citigroup Inc.	27,474	$36K	0.0%	+78.3%	0.011%
11/9/2021	BlackRock Inc.	13,566,265	$17.64M	0.0%	+0.6%	5.325%
11/9/2021	Boston Private Wealth LLC	26,000	$34K	0.0%	N/A	0.010%
11/8/2021	State Board of Administration of Florida Retirement System	52,330	$68K	0.0%	N/A	0.021%
11/5/2021	Advisor Group Holdings Inc.	62,547	$81K	0.0%	+84.0%	0.025%
11/4/2021	Almanack Investment Partners LLC.	40,850	$53K	0.0%	-21.7%	0.016%
11/4/2021	Deutsche Bank AG	1,078,613	$1.40M	0.0%	-65.9%	0.423%
11/2/2021	New York State Common Retirement Fund	103,586	$0.14M	0.0%	-43.1%	0.041%
11/1/2021	SG Americas Securities LLC	107,970	$0.14M	0.0%	+292.0%	0.042%
10/29/2021	Commonwealth Equity Services LLC	153,052	$0.20M	0.0%	+101.4%	0.060%
10/29/2021	ODonnell Financial Services LLC	840,727	$1.09M	0.5%	N/A	0.330%
10/15/2021	Paradigm Strategies in Wealth Management LLC	30,800	$40K	0.0%	+185.2%	0.012%
9/17/2021	Virtu Financial LLC	168,722	$0.19M	0.0%	+42.4%	0.066%
8/17/2021	Millennium Management LLC	2,806,866	$3.09M	0.0%	+50.0%	1.117%
8/16/2021	Squarepoint Ops LLC	23,262	$26K	0.0%	-84.0%	0.009%
8/16/2021	Amalgamated Bank	40,133	$44K	0.0%	N/A	0.016%
8/16/2021	Cubist Systematic Strategies LLC	208,581	$0.23M	0.0%	+388.5%	0.083%
8/16/2021	California State Teachers Retirement System	293,497	$0.32M	0.0%	N/A	0.117%
8/16/2021	Charles Schwab Investment Management Inc.	518,627	$0.57M	0.0%	+662.2%	0.206%
8/16/2021	State Street Corp	2,976,803	$3.27M	0.0%	N/A	1.184%
8/16/2021	Nuveen Asset Management LLC	1,213,239	$1.33M	0.0%	N/A	0.483%
8/13/2021	Renaissance Technologies LLC	1,305,027	$1.44M	0.0%	N/A	0.519%
8/13/2021	Northern Trust Corp	733,042	$0.81M	0.0%	+128.5%	0.292%
8/13/2021	Qube Research & Technologies Ltd	274,665	$0.30M	0.0%	+27.0%	0.109%
8/13/2021	Geode Capital Management LLC	3,373,509	$3.71M	0.0%	+157.7%	1.342%
8/13/2021	Vanguard Group Inc.	10,925,887	$12.02M	0.0%	+21.5%	4.347%
8/13/2021	ProShare Advisors LLC	55,135	$61K	0.0%	N/A	0.022%
8/12/2021	SG Americas Securities LLC	27,541	$30K	0.0%	N/A	0.011%
8/12/2021	Legal & General Group Plc	22,477	$25K	0.0%	N/A	0.009%
8/12/2021	JPMorgan Chase & Co.	139,530	$0.15M	0.0%	N/A	0.056%
8/12/2021	The Manufacturers Life Insurance Company	141,330	$0.16M	0.0%	N/A	0.056%
8/11/2021	Bank of New York Mellon Corp	481,547	$0.53M	0.0%	+727.7%	0.192%
8/11/2021	BlackRock Inc.	13,484,537	$14.83M	0.0%	+258.5%	5.364%
8/11/2021	Deutsche Bank AG	3,165,872	$3.48M	0.0%	+2,367.3%	1.259%
8/10/2021	Principal Financial Group Inc.	83,859	$92K	0.0%	N/A	0.033%
8/5/2021	Rhumbline Advisers	144,474	$0.16M	0.0%	N/A	0.057%
8/2/2021	New York State Common Retirement Fund	182,100	$0.20M	0.0%	N/A	0.072%
8/2/2021	Advisor Group Holdings Inc.	34,000	$38K	0.0%	+126.7%	0.014%

Data available starting January 2016

9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders in North America. Its lead product candidate is Vurolenatide, a long-acting injectable glucagon-like-peptide-1 that is in Phase 3 clinical trial to treat short bowel syndrome. The company is developing NM-136, a humanized monoclonal antibody for the treatment of obesity and obesity-related disorders; NM-102, a small molecule peptide to prevent antigens from trafficking into systemic circulation; and NM-003, a proprietary long-acting glucagon-like peptide-2 receptor agonist for prevention of acute graft versus host disease. Its partnered product is Larazotide, an 8-amino acid peptide, which is in Phase 2 clinical trial for treatment of multi-system inflammatory syndrome. The company has licensing agreements with Amunix, MHS Care Innovation LLC, Alba Therapeutics Corporation, and EBRIS. 9 Meters Biopharma, Inc. is headquartered in Raleigh, North Carolina. On July 17, 2023, 9 Meters Biopharma, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Eastern District of North Carolina.

Today's Range

Now: $0.01

$0.01

$0.02

50 Day Range

MA: $0.02

$0.01

$0.13

52 Week Range

Now: $0.01

$0.07

$6.56

Volume

10,046 shs

Average Volume

315,915 shs

Market Capitalization

$172,032.00

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.36

Who are the company insiders with the largest holdings of 9 Meters Biopharma?: 9 Meters Biopharma's top insider shareholders include:
Mark A Sirgo (Director)
John Temperato (CEO)
Bethany Sensenig (CFO)
Learn More about top insider investors at 9 Meters Biopharma.